Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma.
Rath C, Yoo C, Cheplowitz H, Lo M, Young R, Guglielmo J, Saunders IM, Banerjee R, Young R, Kumar A, Chung A, Rosenberg AS, Costello C, Fine J, Wilson M, Patel N, Banez MT.
Rath C, et al. Among authors: chung a.
J Oncol Pharm Pract. 2023 Oct;29(7):1715-1724. doi: 10.1177/10781552221150935. Epub 2023 Feb 2.
J Oncol Pharm Pract. 2023.
PMID: 36731514